Skip to main content

Table 10 C-index analysis of the prognostic accuracy of HECW1 and other variables for overall survival and progression-free survival in the training cohort (n = 180) and validation cohort (n = 120) (3:2 ratio)

From: Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma

Characteristics

Overall survival

Progression-free survival

training cohort(n = 180)

validation cohort(n = 120)

training cohort(n = 180)

validation cohort(n = 120)

TNM stage

0.700(0.601–0.799)

0.608(0.512–0.704)

0.699(0.616–0.782)

0.606(0.469–0.607)

SSIGN

0.647(0.549–0.745)

0.608(0.511–0.705)

0.684(0.598–0.770)

0.624(0.536–0.728)

HECW1

0.825(0.790–0.860)

0.807(0.755–0.859)

0.791(0.749–0.833)

0.828(0.786–0.874)

HECW1 + TNM

0.876(0.833–0.919)

0.822(0.768–0.876)

0.842(0.796–0.888)

0.836(0.761–0.863)

HECW1 + SSIGN

0.870(0.825–0.915)

0.830(0.771–0.889)

0.854(0.803–0.905)

0.857(0.817–0.911)

  1. SSIGN Stage, Size, Grade, and Necrosis, TNM Tumor Node Metastasis